Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

NEULAND LABS Fact Sheet  (NELB)



Don't Miss: Best Chance to Access Midcap Stocks Research at 80% OFF


Here is the latest financial fact sheet of NEULAND LABS. For more details, see the NEULAND LABS quarterly results and NEULAND LABS share price. For a sector overview, read our pharmaceuticals sector report.

NEULAND LABS Price History

Price Rs 7,350.0
Mkt Cap Rs m 94,300
Vol '000 0.6
P/E X 29.7
P/CF X 43.6
EPS (TTM) Rs 247.1
1 Day % -4.0
No. of shares m 12.83
1 Week % 18.1
1 Month % 17.3
1 Year % 257.9
52 week H/L Rs 7,794.0/1,947.0
As on Apr 19, 2024 09:46:00 AM
* Results Consolidated
Excel EXPORT | DO YOU LIKE THESE FACTSHEETS? TELL US!

NEULAND LABS Financials

No. of Mths
Year Ending
12
Mar-19
*
12
Mar-20
*
12
Mar-21
*
12
Mar-22
*
12
Mar-23
*
5-Yr Chart
Click to enlarge
NEULAND LABS EQUITY SHARE DATA
High Rs8287542,3502,8402,004 
Low Rs4312472601,000966 
Sales per share (Unadj.) Rs519.7594.5730.3741.3928.4 
Earnings per share (Unadj.) Rs12.812.662.849.7127.4 
Diluted earnings per shareRs12.812.662.849.7127.5 
Cash flow per share (Unadj.) Rs33.037.093.888.0168.6 
Dividends per share (Unadj.) Rs1.202.005.005.0010.00 
Adj. dividends per shareRs1.202.005.005.0010.00 
Avg Dividend yield %0.20.40.40.30.7 
Book value per share (Unadj.) Rs545.1553.4613.0655.1774.8 
Adj. book value per shareRs545.1553.4613.0655.1774.8 
Shares outstanding (eoy) m12.8312.8312.8312.8312.83 
Bonus / Rights / Conversions  00000 
Price / Sales ratio x1.20.81.82.61.6 
Avg P/E ratio x49.139.620.838.611.7 
P/CF ratio (eoy) x19.113.513.921.88.8 
Price / Book Value ratio x1.20.92.12.91.9 
Dividend payout %9.415.88.010.17.8 
Avg Mkt Cap Rs m8,0786,42116,74624,63319,052 
No. of employees `000NANANANANA 
Total wages/salary Rs m1,1051,2361,4971,8252,018 
Avg. sales/employee Rs Th00000 
Avg. wages/employee Rs Th00000 
Avg. net profit/employee Rs Th00000 
NEULAND LABS INCOME DATA
Net Sales Rs m6,6687,6279,3699,51111,912 
Other income Rs m35391612197 
Total revenues Rs m6,7037,6669,5309,53212,009 
Gross profit Rs m5841,0191,4681,4262,718 
Depreciation Rs m259313397490528 
Interest Rs m157216179135131 
Profit before tax Rs m2035291,0538222,157 
Minority Interest Rs m00000 
Prior Period Items Rs m00000 
Extraordinary Inc (Exp) Rs m00000 
Tax Rs m39367247183522 
Profit after tax Rs m1641628066381,635 
Gross profit margin %8.813.415.715.022.8 
Effective tax rate %19.269.423.522.324.2 
Net profit margin %2.52.18.66.713.7 
NEULAND LABS BALANCE SHEET DATA
Current assets Rs m4,5355,1525,4965,8087,609 
Current liabilities Rs m3,2703,5763,6853,6324,390 
Net working cap to sales %19.020.719.322.927.0 
Current ratio x1.41.41.51.61.7 
Inventory Days Days21221976 
Debtors Days Days8989098488991,109 
Net fixed assets Rs m6,7697,1587,7528,0278,189 
Share capital Rs m129129129129129 
"Free" reserves Rs m6,8646,9717,7368,2769,812 
Net worth Rs m6,9937,1007,8658,4059,941 
Long term debt Rs m6077748811,042742 
Total assets Rs m11,30412,31013,24813,83515,798 
Interest coverage x2.33.56.97.117.5 
Debt to equity ratio x0.10.10.10.10.1 
Sales to assets ratio x0.60.60.70.70.8 
Return on assets %2.83.17.45.611.2 
Return on equity %2.42.310.37.616.4 
Return on capital %4.79.514.110.121.4 
Exports to sales %72.568.077.872.173.5 
Imports to sales %25.220.929.517.015.1 
Exports (fob) Rs m4,8355,1877,2926,8588,750 
Imports (cif) Rs m1,6811,5932,7651,6131,804 
Fx inflow Rs m4,8355,1877,2926,8588,750 
Fx outflow Rs m1,6811,5932,7651,6131,804 
Net fx Rs m3,1543,5944,5275,2456,946 
NEULAND LABS CASH FLOW
From Operations Rs m 699 573 1,894 604 2,372 
From Investments Rs m -772 -487 -844 -955 -615 
From Financial Activity Rs m 120 -55 -1,137 377 -1,358 
Net Cashflow Rs m 47 33 -88 27 403 
* Results Consolidated
Source: Accord Fintech, Equitymaster

Share Holding

Promoters 32.7%
Institution 31.4%
Non-Institution 35.9%
Total 100.0%
Free Float 67.3%
Pledged promoter holdings 0.0%
Shareholding as on Mar 2024
 

Company Information

Regd Off 11th Floor (5th Office Level), Phoenix I V Y Building Plot No.573 A- I I I, Road No. 82 Jubilee Hills, Hyderabad - 500033
E-mail neuland@neulandlabs.com Web www.neulandlabs.com
Tel 040-67611600 / 67611700 Fax 040-30211602
Sector PHARMACEUTICALS Group Private sector
Tr Agent K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.), Karvy Selenium Tower B Plot 31-32, Gachibowli Financial District, Nanakramguda
CHM: Davuluri Rama Mohan Rao COMP SEC: Sarada Bhamidipati YEAR OF INC: 1984 BSE CODE: 524558 FV (Rs): 10 DIV YIELD (%): 0.1

Read: NEULAND LABS 2022-23 Annual Report Analysis

More Pharmaceuticals Company Fact Sheets:   DIVIS LABORATORIES    DR. REDDYS LAB    ZYDUS LIFESCIENCES    CIPLA    SUN PHARMA    

Compare NEULAND LABS With:   DIVIS LABORATORIES    DR. REDDYS LAB    ZYDUS LIFESCIENCES    CIPLA    SUN PHARMA    



 

Today's Market

Gift Nifty Down 342 Points | Tata Motors to Make JLR Cars in Tamil Nadu | Kronox Lab Sciences to Launch IPO | Top Buzzing Stocks Today Gift Nifty Down 342 Points | Tata Motors to Make JLR Cars in Tamil Nadu | Kronox Lab Sciences to Launch IPO | Top Buzzing Stocks Today(Pre-Open)

It was indeed a volatile trading session for Indian share markets yesterday.